<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — Januar 2012]]></title><description><![CDATA[<p dir="auto">Bloomberg: Genmab er opkøbskandidat</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/451442/genmab-januar-2012</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 00:51:08 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/451442.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 13 Jan 2012 12:40:20 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — Januar 2012 on Tue, 24 Jan 2012 08:05:21 GMT]]></title><description><![CDATA[<p dir="auto">hvem banker pandora ned?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067313</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067313</guid><dc:creator><![CDATA[HRmunk]]></dc:creator><pubDate>Tue, 24 Jan 2012 08:05:21 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2012 on Wed, 18 Jan 2012 07:19:43 GMT]]></title><description><![CDATA[<p dir="auto">Umuligt at svare på.  Udfaldet af 1.line CLL studiet til marts 2013, kan gøre at Genmab er 1 eller 10mia værd... <a href="http://clinicaltrials.gov/ct2/show/NCT00748189?term=ofatumumab+chlorambucil&amp;rank=1" rel="nofollow ugc">http://clinicaltrials.gov/ct2/show/NCT00748189?term=ofatumumab+chlorambucil&amp;rank=1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067310</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067310</guid><dc:creator><![CDATA[MadsSkjern]]></dc:creator><pubDate>Wed, 18 Jan 2012 07:19:43 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2012 on Wed, 18 Jan 2012 05:15:50 GMT]]></title><description><![CDATA[<p dir="auto">Men både Jan og Bloomberg nævner det som en mulighed. Og med den pris der er nu skulle prisen så være x 2 eller 3??</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067311</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067311</guid><dc:creator><![CDATA[Blockbuster]]></dc:creator><pubDate>Wed, 18 Jan 2012 05:15:50 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2012 on Sat, 14 Jan 2012 13:12:32 GMT]]></title><description><![CDATA[<p dir="auto">Tror ikke på opkøb, da GSK sidder på 10% af aktierne. GSK er ikke interesserede i opkøb, da deres strategi er at samarbejde med biotekfirmaer - ikke eje dem.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067309</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067309</guid><dc:creator><![CDATA[MadsSkjern]]></dc:creator><pubDate>Sat, 14 Jan 2012 13:12:32 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2012 on Fri, 13 Jan 2012 14:46:57 GMT]]></title><description><![CDATA[<p dir="auto">Hvis der kom et opkøbstilbud på mandag. Hvor højt skulle det bud mon så være??</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10067312</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10067312</guid><dc:creator><![CDATA[Blockbuster]]></dc:creator><pubDate>Fri, 13 Jan 2012 14:46:57 GMT</pubDate></item></channel></rss>